David Croucher
Garvan Institute of Medical Research, NSW, Australia
- This delegate is presenting an abstract at this event.
David completed his undergraduate studies and Ph.D. research at the University of Wollongong, followed by a post-doctoral position at the Garvan Institute, all of which focused on the characterisation of individual signalling proteins in the behaviour of cancer cells. Pursuing the idea that these cancer-related proteins do not act in isolation, but are actually embedded within dynamic networks, David undertook a second post-doctoral position at Systems Biology Ireland in University College Dublin. After establishing an independent research group at Systems Biology Ireland, David received a Future Research Leader grant from Cancer Institute NSW and returned to the Garvan Institute as head of the Network Biology group. The focus of his research group is the investigation of network level aberrations induced by oncogenes and oncogenic mutations, ultimately aiming to elucidate how altered network behaviour leads to therapeutic resistance
Presentations this author is a contributor to:
Establishment of patient-derived models of metastatic appendiceal cancers (#208)
5:35 PM
King Ho Leong
Poster Session 2
Rationalising the inclusion of HDAC inhibitors with standard-of-care chemotherapy for high-risk neuroblastoma (#238)
5:35 PM
Monica Phimmachanh
Poster Session 2
Pancreatic cancer secretome reveals PCSK9 as a co-target to sensitise tumours to chemotherapy and reduce metastasis (#244)
5:35 PM
Shona Ritchie
Poster Session 2
Targeting subcellular JNK activity in pancreatic cancer (#123)
5:40 PM
Antonia Cadell
Welcome Reception & Poster Session 1
CANCER 2026